161 related articles for article (PubMed ID: 10380355)
21. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
[TBL] [Abstract][Full Text] [Related]
22. Electron immunohistochemical localization in rat bronchiolar epithelial cells of tryptase Clara, which determines the pneumotropism and pathogenicity of Sendai virus and influenza virus.
Sakai K; Kawaguchi Y; Kishino Y; Kido H
J Histochem Cytochem; 1993 Jan; 41(1):89-93. PubMed ID: 8380186
[TBL] [Abstract][Full Text] [Related]
23. Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus.
Murakami M; Towatari T; Ohuchi M; Shiota M; Akao M; Okumura Y; Parry MA; Kido H
Eur J Biochem; 2001 May; 268(10):2847-55. PubMed ID: 11358500
[TBL] [Abstract][Full Text] [Related]
24. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
25. Antibody against the carboxyl terminus of the F2 subunit of Sendai virus fusion glycoprotein inhibits proteolytic activation.
Tashiro M; Takeda M; Tanaka S; Nishimura N; Takenaka M; Kido H
Virology; 1993 Jun; 194(2):882-5. PubMed ID: 8389088
[TBL] [Abstract][Full Text] [Related]
26. Role of primary constitutive phosphorylation of Sendai virus P and V proteins in viral replication and pathogenesis.
Hu CJ; Kato A; Bowman MC; Kiyotani K; Yoshida T; Moyer SA; Nagai Y; Gupta KC
Virology; 1999 Oct; 263(1):195-208. PubMed ID: 10544094
[TBL] [Abstract][Full Text] [Related]
27. Histone-tryptase interaction: H2A N-terminal tail removal and inhibitory activity.
Fiorucci L; Erba F; Ascoli F
Arch Biochem Biophys; 1997 Nov; 347(2):229-34. PubMed ID: 9367529
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
Scarpi D; McBride JD; Leatherbarrow RJ
Bioorg Med Chem; 2004 Dec; 12(23):6045-52. PubMed ID: 15519150
[TBL] [Abstract][Full Text] [Related]
29. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.
Nakajima S; Nobusawa E; Nakajima K
Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103
[TBL] [Abstract][Full Text] [Related]
30. Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells.
Nishiyama K; Sugawara K; Nouchi T; Kawano N; Soejima K; Abe S; Mizokami H
Biologicals; 2008 Mar; 36(2):122-33. PubMed ID: 17892946
[TBL] [Abstract][Full Text] [Related]
31. Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution.
Jayakumar A; Kang Y; Henderson Y; Mitsudo K; Liu X; Briggs K; Wang M; Frederick MJ; El-Naggar AK; Bebök Z; Clayman GL
Arch Biochem Biophys; 2005 Mar; 435(1):89-102. PubMed ID: 15680911
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
33. Cyanobacteria a potential source of antiviral substances against influenza virus.
Zainuddin EN; Mundt S; Wegner U; Mentel R
Med Microbiol Immunol; 2002 Dec; 191(3-4):181-2. PubMed ID: 12458356
[TBL] [Abstract][Full Text] [Related]
34. Accumulation of mini-plasmin in the cerebral capillaries causes vascular invasion of the murine brain by a pneumotropic influenza A virus: implications for influenza-associated encephalopathy.
Yao D; Chen Y; Kuwajima M; Shiota M; Kido H
Biol Chem; 2004 Jun; 385(6):487-92. PubMed ID: 15255180
[TBL] [Abstract][Full Text] [Related]
35. [Various sides of influenza, part I--structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics].
Machała MK; Brydak LB
Pol Merkur Lekarski; 2006 Sep; 21(123):270-6. PubMed ID: 17163190
[TBL] [Abstract][Full Text] [Related]
36. Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus.
Zhirnov OP; Matrosovich TY; Matrosovich MN; Klenk HD
Antivir Chem Chemother; 2011 Mar; 21(4):169-74. PubMed ID: 21602614
[TBL] [Abstract][Full Text] [Related]
37. A double WAP domain (DWD)-containing protein with proteinase inhibitory activity in Chinese white shrimp, Fenneropenaeus chinensis.
Du ZQ; Ren Q; Zhao XF; Wang JX
Comp Biochem Physiol B Biochem Mol Biol; 2009 Oct; 154(2):203-10. PubMed ID: 19545640
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays.
Hagiwara K; Kondoh Y; Ueda A; Yamada K; Goto H; Watanabe T; Nakata T; Osada H; Aida Y
Biochem Biophys Res Commun; 2010 Apr; 394(3):721-7. PubMed ID: 20230782
[TBL] [Abstract][Full Text] [Related]
39. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
Teng MN; Whitehead SS; Collins PL
Virology; 2001 Oct; 289(2):283-96. PubMed ID: 11689051
[TBL] [Abstract][Full Text] [Related]
40. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
